Maravai LifeSciences MRVI Stock
Maravai LifeSciences Price Chart
Maravai LifeSciences MRVI Financial and Trading Overview
Maravai LifeSciences stock price | 1.99 USD |
Previous Close | 13.95 USD |
Open | 13.9 USD |
Bid | 0 USD x 2200 |
Ask | 0 USD x 800 |
Day's Range | 13.32 - 14.21 USD |
52 Week Range | 11.59 - 30.44 USD |
Volume | 1.98M USD |
Avg. Volume | 2.49M USD |
Market Cap | 3.36B USD |
Beta (5Y Monthly) | -0.231925 |
PE Ratio (TTM) | 11.754386 |
EPS (TTM) | -1.05 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.82 USD |
MRVI Valuation Measures
Enterprise Value | 2.19B USD |
Trailing P/E | 11.754386 |
Forward P/E | 34.358974 |
PEG Ratio (5 yr expected) | -1.5 |
Price/Sales (ttm) | 4.6858263 |
Price/Book (mrq) | 3.3864038 |
Enterprise Value/Revenue | 3.058 |
Enterprise Value/EBITDA | 5.033 |
Trading Information
Maravai LifeSciences Stock Price History
Beta (5Y Monthly) | -0.231925 |
52-Week Change | -49.69% |
S&P500 52-Week Change | 20.43% |
52 Week High | 30.44 USD |
52 Week Low | 11.59 USD |
50-Day Moving Average | 13.61 USD |
200-Day Moving Average | 15.63 USD |
MRVI Share Statistics
Avg. Volume (3 month) | 2.49M USD |
Avg. Daily Volume (10-Days) | 1.72M USD |
Shares Outstanding | 131.79M |
Float | 109.87M |
Short Ratio | 1.43 |
% Held by Insiders | 0.56% |
% Held by Institutions | 98.13% |
Shares Short | 6.32M |
Short % of Float | 5.75% |
Short % of Shares Outstanding | 4.79% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 21.35% |
Operating Margin (ttm) | 56.10% |
Gross Margin | 77.34% |
EBITDA Margin | 60.74% |
Management Effectiveness
Return on Assets (ttm) | 11.54% |
Return on Equity (ttm) | 44.04% |
Income Statement
Revenue (ttm) | 717.73M USD |
Revenue Per Share (ttm) | 5.45 USD |
Quarterly Revenue Growth (yoy) | -67.70% |
Gross Profit (ttm) | 714.04M USD |
EBITDA | 435.98M USD |
Net Income Avi to Common (ttm) | 153.28M USD |
Diluted EPS (ttm) | 1.14 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 628.27M USD |
Total Cash Per Share (mrq) | 4.76 USD |
Total Debt (mrq) | 603.8M USD |
Total Debt/Equity (mrq) | 67.04 USD |
Current Ratio (mrq) | 6.129 |
Book Value Per Share (mrq) | 3.957 |
Cash Flow Statement
Operating Cash Flow (ttm) | 458.75M USD |
Levered Free Cash Flow (ttm) | 356.17M USD |
Profile of Maravai LifeSciences
Country | United States |
State | CA |
City | San Diego |
Address | 10770 Wateridge Circle |
ZIP | 92121 |
Phone | 858 546 0004 |
Website | https://www.maravai.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 650 |
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, Viral Clearance Prediction kits, and custom services. It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.
Q&A For Maravai LifeSciences Stock
What is a current MRVI stock price?
Maravai LifeSciences MRVI stock price today per share is 1.99 USD.
How to purchase Maravai LifeSciences stock?
You can buy MRVI shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Maravai LifeSciences?
The stock symbol or ticker of Maravai LifeSciences is MRVI.
Which industry does the Maravai LifeSciences company belong to?
The Maravai LifeSciences industry is Biotechnology.
How many shares does Maravai LifeSciences have in circulation?
The max supply of Maravai LifeSciences shares is 247.95M.
What is Maravai LifeSciences Price to Earnings Ratio (PE Ratio)?
Maravai LifeSciences PE Ratio is now.
What was Maravai LifeSciences earnings per share over the trailing 12 months (TTM)?
Maravai LifeSciences EPS is -1.05 USD over the trailing 12 months.
Which sector does the Maravai LifeSciences company belong to?
The Maravai LifeSciences sector is Healthcare.
Maravai LifeSciences MRVI included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15603.26 USD — |
+0.1
|
10.08B USD — | 14784.03 USD — | 16292.28 USD — | — - | 10.08B USD — |
NASDAQ Biotechnology NBI | 3856.67 USD — |
-1.22
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
NASDAQ HealthCare IXHC | 865.57 USD — |
-0.49
|
— — | 828.4 USD — | 890 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 7634.31 USD — |
+0.11
|
— — | 7233.89 USD — | 7972.89 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
Nasdaq US 700 Small Cap Index NQUS700SC | 1913.4 USD — |
-1.32
|
— — | 1835.13 USD — | 2001.25 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2497.76 USD — |
-0.11
|
— — | 2369.22 USD — | 2594.76 USD — | — - | — — |
- {{ link.label }} {{link}}